(Fifth Disease, Erythema Infectiosum)
Definition
A mild, self-limiting viral infection most commonly affecting children, caused by parvovirus B19, characterized by a bright red rash on the cheeks followed by a lacy rash on the body.
Cause
-
Parvovirus B19 — spreads via respiratory droplets, blood transfusion, or vertically from mother to fetus
Risk Groups
-
Children aged 3–15 years
-
Adults in contact with children (teachers, healthcare workers)
-
Immunocompromised individuals
-
Pregnant women (risk of fetal hydrops)
Pathophysiology
-
Virus infects and destroys erythroid progenitor cells in bone marrow
-
Causes a brief drop in red cell production, which may trigger anaemia in susceptible patients (e.g., sickle cell disease)
-
Immune-mediated skin rash appears after viraemia resolves
Clinical Features
Stage 1 – Initial Phase (Viraemia)
-
Low-grade fever
-
Malaise, headache, mild cold-like symptoms
-
Lasts 2–5 days; infectious at this stage
Stage 2 – Rash Phase
-
Bright red “slapped cheek” facial rash
-
Lacy, reticular maculopapular rash on trunk and limbs
-
Rash may recur with heat, exercise, or sunlight
-
Usually non-itchy in children; more pruritic in adults
Stage 3 – Arthropathy (especially in adults)
-
Symmetrical joint pain and swelling (hands, wrists, knees, ankles)
-
Lasts days to weeks
Complications
-
Aplastic crisis in haemolytic anaemias
-
Fetal hydrops and miscarriage in pregnant women infected during early pregnancy
-
Chronic anaemia in immunocompromised patients
Diagnosis
-
Clinical diagnosis based on typical rash pattern in children
-
Confirm with Parvovirus B19 IgM antibodies in high-risk groups (pregnant women, immunosuppressed)
-
PCR testing in immunocompromised or atypical cases
Treatment
General
-
No specific antiviral treatment; supportive care only
-
Rest, adequate hydration
-
Paracetamol 500–1000 mg every 4–6 hours (max 4 g/day) or ibuprofen 200–400 mg every 6–8 hours for fever and discomfort
Special Situations
-
Immunocompromised or severe anaemia: consider hospital admission and intravenous immunoglobulin (IVIG)
-
Pregnant women: monitor fetal wellbeing with ultrasound if infection confirmed
Prevention
-
Good hand hygiene
-
No vaccine available
-
Exclusion from school not required once rash appears (non-infectious phase)
Quick-Reference Clinical Chart — Slapped Cheek Syndrome
Feature | Details |
---|---|
Definition | Viral childhood illness caused by parvovirus B19 with bright red cheek rash |
Transmission | Respiratory droplets, blood, vertical (mother to fetus) |
Incubation | 4–14 days (up to 21) |
Symptoms | Fever, malaise → “slapped cheek” rash → lacy body rash; joint pain in adults |
Complications | Aplastic crisis, fetal hydrops, chronic anaemia |
Treatment | Supportive: rest, fluids, paracetamol 500–1000 mg Q4–6h PRN or ibuprofen 200–400 mg Q6–8h PRN |
Infectious period | Before rash onset; not infectious once rash appears |
Prevention | Hand hygiene, no vaccine, exclude only if unwell |
Prognosis | Full recovery in healthy individuals; severe risk in anaemia, pregnancy, immunosuppression |
No comments:
Post a Comment